ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC33840-10mM(1mLinDMSO) |
|
168835-82-3 |
SU1498 (AG 1498)
|
0 | C25H30N2O2 | |
GC33839-500mg |
|
19515 |
Cortisone (17-Hydroxy-11-dehydrocorticosterone)
|
0 | C21H28O5 | |
GC33839-100mg |
|
19515 |
Cortisone (17-Hydroxy-11-dehydrocorticosterone)
|
0 | C21H28O5 | |
GC33839-10mM(1mLinDMSO) |
|
19515 |
Cortisone (17-Hydroxy-11-dehydrocorticosterone)
|
0 | C21H28O5 | |
GC33838-250mg |
|
345909-26-4 |
Taurocholic Acid sodium hydrate (Sodium taurocholate hydrate)
|
0 | C26H44NO7S.xH2O.Na | |
GC33838-10mM(1mLinWater) |
|
345909-26-4 |
Taurocholic Acid sodium hydrate (Sodium taurocholate hydrate)
|
0 | C26H44NO7S.xH2O.Na | |
GC33837-100mg |
|
904763-27-5 |
ATN-161 trifluoroacetate salt (ATN-161 TFA salt)
|
0 | C25H36F3N9O10S | |
GC33837-50mg |
|
904763-27-5 |
ATN-161 trifluoroacetate salt (ATN-161 TFA salt)
|
0 | C25H36F3N9O10S | |
GC33837-10mg |
|
904763-27-5 |
ATN-161 trifluoroacetate salt (ATN-161 TFA salt)
|
0 | C25H36F3N9O10S | |
GC33837-5mg |
|
904763-27-5 |
ATN-161 trifluoroacetate salt (ATN-161 TFA salt)
|
0 | C25H36F3N9O10S | |
GC33837-2mg |
|
904763-27-5 |
ATN-161 trifluoroacetate salt (ATN-161 TFA salt)
|
0 | C25H36F3N9O10S | |
GC33836-100mg |
|
1218816-71-7 |
SK1-IN-1
|
0 | C22H30N4O3 | |
GC33836-50mg |
|
1218816-71-7 |
SK1-IN-1
|
0 | C22H30N4O3 | |
GC33836-25mg |
|
1218816-71-7 |
SK1-IN-1
|
0 | C22H30N4O3 | |
GC33836-10mg |
|
1218816-71-7 |
SK1-IN-1
|
0 | C22H30N4O3 | |
GC33836-5mg |
|
1218816-71-7 |
SK1-IN-1
|
0 | C22H30N4O3 | |
GC33836-1mg |
|
1218816-71-7 |
SK1-IN-1
|
0 | C22H30N4O3 | |
GC33836-10mM(1mLinDMSO) |
|
1218816-71-7 |
SK1-IN-1
|
0 | C22H30N4O3 | |
GC33835-50mg |
|
1672-46-4 |
Digoxigenin (Lanadigenin)
|
0 | C23H34O5 | |
GC33835-10mg |
|
1672-46-4 |
Digoxigenin (Lanadigenin)
|
0 | C23H34O5 | |